Gapping down
Select paper/packaging related names showing weakness: IP -4.1%, TIN -3.7%, PKG -2.1%.
Other news: OPEN -2.6% (weakness attributed to negative mention in financial newspaper), MMR -2.5% (to acquire Gulf of Mexico shallow water shelf properties from Plains Exploration & Production), TGB -1.4% (files preliminary base shelf prospectus), HIG -1.3% (discloses, in 424B7 filing, that the US Department of the Treasury offering to sell 52,093,973 warrants).
Analyst comments: EXPE -1.9% (downgraded to Neutral from Positive at Susquehanna), X -1.3% and NUE -1.0% (downgraded to Neutral from Buy at Goldman), PPL -0.9% (downgraded to Hold from Buy at Deutsche Bank), LZ -0.7% (downgraded to Hold from Buy at Deutsche Bank).
Gapping up
In reaction to strong earnings/guidance: LEN +5.8%, CBE +2.3% (light volume).
M&A news: RAE +49.0% (ticking higher; RAE Systems to be acquired by Battery Ventures for $1.60/Share ), ID +21.1% (L-1 Identity Solutions to be acquired by Safran for $12.00/Share; sells its Intelligence Services Group to BAE Systems), NZ +13.0% (Netezza to be acquired by IBM for $27/share).
Select metals/mining stocks trading higher: GOLD +1.2%, BHP +1.2%, HL +1.2%, SLW +1.1%, AA +1.1%, ABX +0.9%.
Select oil/gas related names showing strength: TOT +2.0%, PXP +2.0% (McMoRan Exploration (MMR) to acquire Gulf of Mexico shallow water shelf properties from Plains Exploration & Production), RDS.A +1.1%, RIG +1.0%, BP +0.8% (confirms well kill at MC252; will now proceed to complete the abandonment , .
Select European drug names trading higher: NVS +1.9%, GSK +1.2%.
Other news: CHTP +58.1% (reports phase III trial of Northera met primary endpoint and achieved highly significant symptomatic benefits in Neurogenic Orthostatic Hypotension), VRML +7.4% (announced that its OVA1 Test is now CE marked, which is a requirement for marketing the test in the European Union), KCP +3.6% (saw late jump in headline that co may be in talks with Iconix), UN +2.5% (hearing EU extended Unilever and Sara Lee transaction review), NOK +1.4% (still checking), .
Analyst comments: VCLK +3.7% (upgraded to Buy from Hold at The Benchmark Company), BBY +1.5% (upgraded to Outperform at Oppenheimer), FCX +1.4% (upgraded to Buy from Neutral at Goldman), T +1.0% (upgraded to Outperform from Neutral at Credit Suisse), FDO +0.9% (upgraded to Neutral from Sell at Goldman), MDMD +0.6% (initiated with a Buy at Stifel Nicolaus).